What is the Current State of ADC Treatment in EGFR-Amplified Glioblastoma?BySonia Jain, PhDNovember 17th 2025Sonia Jain, PhD, stated that depatuxizumab mafodotin, ABBV-221, and ABBV-321 were 3 of the most prominent ADCs in EGFR-amplified glioblastoma.